Dexamethasone

地塞米松

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameDexamethasone
Drug Alias Namedexamethasone intraocular injection德卡德龙地噻米松氟美松氟甲强的松龙 +[26] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsLabor, InducedDiabetic macular oedemaCoronavirus Disease 2019 (COVID-19) +[138] 
Global Approved IndicationsEndocrine System DiseasesEczemaSerum Sickness +[16] 
Approved Indications in ChinaEczemaDermatitis
Original Approved Country/TerritoryUnited States
Original Approved Date1958/10/30
Country/TerritoryCzechiaBelgiumCanada +[45] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesChildren'S National Research InstituteThe George Institute For Global Health, AustraliaDexcel Pharma Technologies Ltd +[61] 
Inactive CompaniesShireIdrop IncUniversity Of Lahore +[41] 
Active IndicationsLabor, InducedDiabetic macular oedemaCoronavirus Disease 2019 (COVID-19) +[96] 
Inactive IndicationsOcular inflammationEndocrine System DiseasesVitiligo +[42] 

Other Information

ATC CodeA01AC02C05AA09D07AB19 +[11] 
Related LinksWikipediaDrugBankKEGG